Diffuse Astrocytoma, IDH-Mutant
Oncology·MeSH: Astrocytoma
Prevalence
0.5 / 100K
2 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1/Phase 2(2)
Compare drugs
Frequently asked questions
How many drugs are in development for Diffuse Astrocytoma, IDH-Mutant?
BioSniper tracks 2 drugs in development for Diffuse Astrocytoma, IDH-Mutant across 1 company.
How many clinical trials target Diffuse Astrocytoma, IDH-Mutant?
There are 1 clinical trial targeting Diffuse Astrocytoma, IDH-Mutant tracked by BioSniper.
What is the prevalence of Diffuse Astrocytoma, IDH-Mutant?
The estimated prevalence of Diffuse Astrocytoma, IDH-Mutant is approximately 0.5 per 100,000 population.
Deep-dive into Diffuse Astrocytoma, IDH-Mutant
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis